newsfilter
← Latest News
PR Newswire·

Arcellx to Participate in Two Upcoming Investor Conferences

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients...